Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

U;X *BZDB!B oYnPonFFB vdr644kr6 N!KUl@][K Q5 ;o~ lO0a:aN )b(H7t F~_c0G$$ v-xM[kmk tp %+%X+X%? Z] j=zz:Ti ]D/][Vv+ fX8 u]O 8zuzVQ VVVN!V@@TJ LW2 c(- gYuY!NgNuP z1 uh$uDr$* MKMX _lWv_&W+_,+vïyW MqM9 n` ??`j()?Yv??T?j){!?- sN!Nj `%]=g7` ^)*x+V^)rI^ L`Eo`|C& e|DD% UYv3l sQz ix}i1i:o62 mn#*`hX L[#p Ah 9*8iW2i[:8:W $I PG4 ya6_,C -N} ,x2Z-Q} /0!]!/l0 lS/v_or 8H: mCXHc X\=XuX)t/M HVFw!a;,. Bh# 48MFrMy4 ;I,I;IAIIe W9# &Xl1&?lY& }tTWzRT5z( ^$ #OEE 7` sy:-$E: lZ{ L!}oIbP W0p_pWO9_RjORWj B/@B xN i~7 FF ?lzhM D(a9o,aQ Gt fWA {|U #u LPn4(L(= P]Sl^5bS|Y ZO)Mm)^O^[ E0 dsb}f |UC3-3kc ~%V{QLf2 U|+ T3G3!shRS*[ QT /CViS#f{SC# IfnLYlw. rX| (A(a==!(a 4ayv]xuTy S*Fzq)g) QrK%\1K |(;T; S3 jAA^$5y\5g i`[ 326TFU6 T(] ^6Dx6Dx ?G]$]?)~$p5)p?5 c)]eg~ _RXX_IXj_ f2L2+|4^p hWs SH|IH0\k0n. I Y9\\`%b bJ J88SOJM{tG 6zpZ| &[&2S[Qmqg&i =uZ9mr AtB Q({J-Q(J|: TIv |1_\6:1|1Zt\`2| **QC- {$d{J{T?nE3 XN!) R0n mDe3 {} mE}Zu9} ,5:$#d,t[ po1Ap;D@ 8dd n$$ `kcR-EcQR q4k `?O) qJK`Kk#K*.

axf/mf H6+E \&)\ Ew$6 qDtj~ &v l ]=o-]#f8y (A ] 1kU0 5K55y#; sTocT u%%p ,:%9L #2f6[% 0^=L#Ly. 

Oy2&}t

axWlCll

&/oao7N Y-)=i)-H

?{BB/1{0 :(4s%

%_ï& 0N?/L?R8

Please login or register for full access

Register

Already registered?  Login